These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 3428478

  • 1. Rat and human liver vitamin K epoxide reductase: inhibition by thiol blockers and vitamin K1.
    Wallin R, Patrick SD, Martin LF.
    Int J Biochem; 1987; 19(11):1063-8. PubMed ID: 3428478
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Substituted vitamin K epoxide analogues. New competitive inhibitors and substrates of vitamin K1 epoxide reductase.
    Ryall RP, Nandi DL, Silverman RB.
    J Med Chem; 1990 Jun; 33(6):1790-7. PubMed ID: 2342073
    [Abstract] [Full Text] [Related]

  • 4. Vitamin K epoxide reductase activity in the metabolism of epoxides.
    Liptay-Reuter I, Dose K, Guenthner T, Wörner W, Oesch F.
    Biochem Pharmacol; 1985 Aug 01; 34(15):2617-20. PubMed ID: 4015704
    [Abstract] [Full Text] [Related]

  • 5. Warfarin inhibition of vitamin K 2,3-epoxide reductase in rat liver microsomes.
    Fasco MJ, Principe LM, Walsh WA, Friedman PA.
    Biochemistry; 1983 Nov 22; 22(24):5655-60. PubMed ID: 6652076
    [Abstract] [Full Text] [Related]

  • 6. Effect of N-ethylmaleimide on beef and rat liver vitamin K1 epoxide reductase.
    Silverman RB, Nandi DL.
    J Enzyme Inhib; 1990 Nov 22; 3(4):289-94. PubMed ID: 2319331
    [Abstract] [Full Text] [Related]

  • 7. Species comparison of vitamin K1 2,3-epoxide reductase activity in vitro: kinetics and warfarin inhibition.
    Wilson CR, Sauer JM, Carlson GP, Wallin R, Ward MP, Hooser SB.
    Toxicology; 2003 Aug 01; 189(3):191-8. PubMed ID: 12832152
    [Abstract] [Full Text] [Related]

  • 8. Indirect inhibition of vitamin K epoxide reduction by salicylate.
    Hildebrandt E, Suttie JW.
    J Pharm Pharmacol; 1984 Sep 01; 36(9):586-91. PubMed ID: 6149281
    [Abstract] [Full Text] [Related]

  • 9. Effect of warfarin on plasma and liver vitamin K levels and vitamin K epoxide reductase activity in relation to plasma clotting factor levels in rats.
    Yamanaka Y, Yamano M, Yasunaga K, Shike T, Uchida K.
    Thromb Res; 1990 Jan 15; 57(2):205-14. PubMed ID: 2315885
    [Abstract] [Full Text] [Related]

  • 10. Vitamin K epoxide reductase: evidence that vitamin K dihydroquinone is a product of vitamin K epoxide reduction.
    Sherman PA, Sander EG.
    Biochem Biophys Res Commun; 1981 Dec 15; 103(3):997-1005. PubMed ID: 7332587
    [No Abstract] [Full Text] [Related]

  • 11. Vitamin K epoxide reductase activity and its inhibition by warfarin in young and old rats.
    Hallak HO, Wedlund PJ.
    Drug Metab Dispos; 1991 Dec 15; 19(1):278-9. PubMed ID: 1673414
    [No Abstract] [Full Text] [Related]

  • 12. 2-(Fluoromethyl)-3-phytyl-1,4-naphthoquinone and its 2,3-epoxide. Inhibition of vitamin K epoxide reductase.
    Silverman RB, Oliver JS.
    J Med Chem; 1989 Sep 15; 32(9):2138-41. PubMed ID: 2769684
    [Abstract] [Full Text] [Related]

  • 13. A fibroblast cell culture model to study vitamin K metabolism and the inhibition of vitamin K epoxide reductase by known and suspected antagonists.
    Ross PJ, Shearer MJ, Diplock AT, Schey SA.
    Br J Haematol; 1991 Feb 15; 77(2):195-200. PubMed ID: 2004021
    [Abstract] [Full Text] [Related]

  • 14. Effect of N-methyl-thiotetrazole on vitamin K epoxide reductase.
    Creedon KA, Suttie JW.
    Thromb Res; 1986 Oct 15; 44(2):147-53. PubMed ID: 3787564
    [Abstract] [Full Text] [Related]

  • 15. Vitamin K1 hydroquinone formation catalyzed by a microsomal reductase system.
    Fasco MJ, Principe LM.
    Biochem Biophys Res Commun; 1980 Dec 31; 97(4):1487-92. PubMed ID: 7213374
    [No Abstract] [Full Text] [Related]

  • 16. Metabolism of vitamin K and vitamin K 2,3-epoxide via interaction with a common disulfide.
    Lee JJ, Fasco MJ.
    Biochemistry; 1984 May 08; 23(10):2246-52. PubMed ID: 6733086
    [Abstract] [Full Text] [Related]

  • 17. Formation of 3-hydroxy-2,3-dihydrovitamin K1 in vivo: relationship to vitamin K epoxide reductase and warfarin resistance.
    Preusch PC, Suttie JW.
    J Nutr; 1984 May 08; 114(5):902-10. PubMed ID: 6726460
    [Abstract] [Full Text] [Related]

  • 18. Vitamin K-dependent carboxylation and vitamin K metabolism in liver. Effects of warfarin.
    Wallin R, Martin LF.
    J Clin Invest; 1985 Nov 08; 76(5):1879-84. PubMed ID: 3932474
    [Abstract] [Full Text] [Related]

  • 19. Co-purification of microsomal epoxide hydrolase with the warfarin-sensitive vitamin K1 oxide reductase of the vitamin K cycle.
    Guenthner TM, Cai D, Wallin R.
    Biochem Pharmacol; 1998 Jan 15; 55(2):169-75. PubMed ID: 9448739
    [Abstract] [Full Text] [Related]

  • 20. Purification of a vitamin K epoxide reductase that catalyzes conversion of vitamin K 2,3-epoxide to 3-hydroxy-2-methyl-3-phytyl-2,3-dihydronaphthoquinone.
    Mukharji I, Silverman RB.
    Proc Natl Acad Sci U S A; 1985 May 15; 82(9):2713-7. PubMed ID: 3857611
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.